Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Promis Neurosciences Inc. (PMN) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Promis Neurosciences Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1374339.
Total stock buying since 2022: $459,370.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 15,000 | $14,595 | 93,223 | $0 | 0 | $0 |
| 2024 | 1,931,129 | $385,114 | 0 | $0 | 0 | $0 |
| 2022 | 10,000 | $59,661 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 93,223 | $0 | 0 | $0 |
| 2025-02 | 15,000 | $14,595 | 0 | $0 | 0 | $0 |
| 2024-09 | 293,223 | $372,624 | 0 | $0 | 0 | $0 |
| 2024-08 | 10,000 | $12,490 | 0 | $0 | 0 | $0 |
| 2024-07 | 1,627,906 | $0 | 0 | $0 | 0 | $0 |
| 2022-12 | 5,000 | $26,181 | 0 | $0 | 0 | $0 |
| 2022-08 | 4,000 | $23,680 | 0 | $0 | 0 | $0 |
| 2022-07 | 1,000 | $9,800 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-30 | Gordon Michael S | Sale | 93,223 | .00 | 0 |
| 2025-02-10 | Cashman Neil (Chief Scientific Officer) | Buy | 15,000 | .97 | 14,595 |
| 2024-09-24 | Shafmaster Madge K. (Director) | Buy | 70,000 | 1.30 | 91,000 |
| 2024-09-23 | Shafmaster Madge K. (Director) | Buy | 70,000 | 1.28 | 89,670 |
| 2024-09-20 | Shafmaster Madge K. (Director) | Buy | 60,000 | 1.25 | 75,060 |
| 2024-09-17 | Gordon Michael S | Buy | 16,292 | 1.40 | 22,808 |
| 2024-09-16 | Gordon Michael S | Buy | 76,931 | 1.22 | 94,086 |
| 2024-08-14 | Kirwin Patrick D. (Director) | Buy | 10,000 | 1.25 | 12,490 |
| 2024-07-31 | Title 19 Promis | Buy | 465,116 | .00 | 0 |
| 2024-07-31 | Sclar Jeremy M. | Buy | 697,674 | .00 | 0 |
| 2024-07-31 | Gordon Michael S | Buy | 465,116 | .00 | 0 |
| 2022-12-14 | Farfel Gail M (Chief Executive Officer) | Buy | 1,000 | 4.94 | 4,940 |
| 2022-12-12 | Williams Eugene (Director) | Buy | 1,000 | 5.08 | 5,075 |
| 2022-12-09 | Kirwin Patrick D. (Director) | Buy | 1,000 | 4.98 | 4,980 |
| 2022-12-07 | Williams Eugene (Director) | Buy | 1,000 | 5.49 | 5,486 |
| 2022-12-06 | Farfel Gail M (Chief Executive Officer) | Buy | 1,000 | 5.70 | 5,700 |
| 2022-08-17 | Kirwin Patrick D. (Director) | Buy | 4,000 | 5.92 | 23,680 |
| 2022-07-11 | Williams Eugene (Chairman and CEO) | Buy | 1,000 | 9.80 | 9,800 |
Insider trading activities including stock purchases, stock sales, and option exercises of PMN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Promis Neurosciences Inc. (symbol PMN, CIK number 1374339) see the Securities and Exchange Commission (SEC) website.